LENALIDOMIDE IN ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA

被引：0
|
作者：
Tempescul, A. [1 ]
Ianotto, J. C. [1 ]
Guillerm, G. [1 ]
Berthou, C. [1 ]
机构：
[1] Univ Hosp Brest, Brest, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0187
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [41] MANAGEMENT OF MANTLE CELL LYMPHOMA IN THE ELDERLY: A RETROSPECTIVE MULTICENTER STUDY
    Keklik, M.
    Dogu, M.
    Nizam, I.
    Terzi, H.
    Hacioglu, S.
    Erkurt, M.
    Keskin, A.
    Eser, B.
    Cetin, M.
    Unal, A.
    Ilhan, O.
    LEUKEMIA RESEARCH, 2014, 38 : S29 - S29
  • [42] Lenalidomide affects F-Actin cytoskeleton in mantle cell lymphoma cells in vitro
    Gaidarova, Svetlana
    Deyanat-Yazdi, Gordafaried
    Bennett, Brydon
    Lopez-Girona, Antonia
    CANCER RESEARCH, 2009, 69
  • [43] Management of Mantle Cell Lymphoma in the Elderly: Current and Potential Strategies
    Vignon, Marguerite
    Venon, Marie-Dominique
    Hermine, Olivier
    Delarue, Richard
    DRUGS & AGING, 2013, 30 (12) : 979 - 986
  • [44] Mantle-cell lymphoma in the elderly: is it time to CHOP and change?
    Farrell, Katrina
    Rule, Simon
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1855 - 1856
  • [45] Management of Mantle Cell Lymphoma in the Elderly: Current and Potential Strategies
    Marguerite Vignon
    Marie-Dominique Venon
    Olivier Hermine
    Richard Delarue
    Drugs & Aging, 2013, 30 : 979 - 986
  • [46] Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
    Witzig, Thomas E.
    Vose, Julie
    Zinzani, Pier Luigi
    Habermann, Thomas Matthew
    Tuscano, Joseph M.
    Sinha, Rajni
    Williams, Michael E.
    Drach, Johannes W.
    Ramchandren, Rod
    Besisik, Sevgi Kalayoglu
    Zhang, Lei
    Cicero, Sherri
    Fu, Tommy
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
    Wang, Michael
    Fayad, Luis
    Wagner-Bartak, Nicolaus
    Zhang, Liang
    Hagemeister, Fredrick
    Neelapu, Sattva S.
    Samaniego, Felipe
    McLaughlin, Peter
    Fanale, Michelle
    Younes, Anas
    Cabanillas, Fernando
    Fowler, Nathan
    Newberry, Kate J.
    Sun, Luhong
    Young, Ken H.
    Champlin, Richard
    Kwak, Larry
    Feng, Lei
    Badillo, Maria
    Bejarano, Maria
    Hartig, Kimberly
    Chen, Wendy
    Chen, Yiming
    Byrne, Catriona
    Bell, Neda
    Zeldis, Jerome
    Romaguera, Jorge
    LANCET ONCOLOGY, 2012, 13 (07): : 716 - 723
  • [48] Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers
    Zaja, Francesco
    De Luca, Stefano
    Vitolo, Umberto
    Orsucci, Lorella
    Levis, Alessandro
    Salvi, Flavia
    Rusconi, Chiara
    Ravelli, Erika
    Tucci, Alessandra
    Bottelli, Chiara
    Balzarotti, Monica
    Santoro, Armando
    Brusamolino, Ercole
    Bonfichi, Maurizio
    Di Rocco, Alice
    Stelitano, Caterina
    Badini, Luca
    Pileri, Stefano A.
    Volpetti, Stefano
    Saccona, Fabio
    Ciccone, Gianni
    Ferranti, Antonella
    Catacchio, Ivana
    Ria, Roberto
    Vacca, Angelo
    Fanin, Renato
    BLOOD, 2010, 116 (21) : 425 - 426
  • [49] High dose Aracytine, Rituximab, and Dexamethasone based chemotherapy for elderly patients with mantle cell lymphoma
    Kotb, Rami
    Boisjoly, Josie-Anne
    Lepine, Mariette
    Beauregard, Patrice
    Sawan, Bassem
    Turcotte, Eric
    BLOOD, 2007, 110 (11) : 188B - 188B
  • [50] Lenalidomide-Based Treatment Results in Patients with Relapsed/Refractory Lymphoma (Excluding Mantle Cell Lymphoma) Unsuitable for High Dose Combination Chemotherapy
    Dogu, Mehmet H.
    Karismaz, AbdulKadir
    Altindal, Sermin
    Yokus, Osman
    Suyani, Elif
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S15 - S15
12345